Preliminary findings from a phase I, open-label, dose-finding study of SNB-101 in patients with advanced solid tumors

被引：0
|
作者：
Sang, Y. B. [1 ]
Kim, Y. [1 ]
Lee, M. A. [2 ]
Rha, S. Y. [3 ]
Jung, M. [3 ]
Lee, C-K. [3 ]
Park, Y. H. [4 ]
Heo, D. [4 ]
Kim, A. [4 ]
Kim, J. [4 ]
Kim, J-H. [1 ]
机构：
[1] CHA Univ, Med Oncol, CHA Bundang Med Ctr, Seongnam, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Med Oncol, Seoul, South Korea
[3] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Med Oncol, Seoul, South Korea
[4] SN BioSci, Med Oncol, Seongnam, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1863
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
677P
引用
收藏
页码：S474 / S474
页数：1
相关论文
共 50 条
  • [21] An open-label phase I study to evaluate the safety, tolerability and preliminary efficacy of YY001 in patients with advanced solid tumors
    Xue, Liqiong
    Tang, Wenbo
    Zhou, Huan
    Liu, Mulin
    Liu, Yuanyuan
    Wang, Jinhua
    Chen, Jianfeng
    Liu, Mingyao
    Guo, Ye
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] A phase I dose-finding study of sunitinib (SU) in combination with gemcitabine (G) in patients (pts) with advanced solid tumors
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D. P.
    McDermott, D. F.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors*,†
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Yamada, Yasuhide
    Goto, Yasushi
    Tanioka, Maki
    Shibata, Takashi
    Yamada, Kazuhiko
    Asahina, Hajime
    Kawata, Toshio
    Shi, Xiaojin
    Tamura, Tomohide
    CANCER SCIENCE, 2012, 103 (03) : 504 - 509
  • [24] A PHASE I DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH GEMCITABINE (G) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D.
    McDermott, D.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [25] Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study
    Hajime Asahina
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Yosuke Tamura
    Kazunori Honda
    Yoshitaka Seki
    Yuko Tanabe
    Hitoshi Shimada
    Xiaojin Shi
    Tomohide Tamura
    Investigational New Drugs, 2013, 31 : 677 - 684
  • [26] Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors
    Johnston, Donna L.
    Zupanec, Susan
    Nicksy, Darcy
    Morgenstern, Daniel
    Narendran, Aru
    Deyell, Rebecca J.
    Samson, Yvan
    Wu, Bing
    Baruchel, Sylvain
    PEDIATRIC BLOOD & CANCER, 2019, 66 (06)
  • [27] A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors
    Richardson, Gary Edward
    Al-Rajabi, Raed
    Uprety, Dipesh
    Hamid, Anis
    Williamson, Stephen K.
    Baranda, Joaquina
    Mamdani, Hirva
    Lee, Ya-Li
    Li, Li
    Wang, Xingli
    Dong, Xunwei
    CANCERS, 2023, 15 (09)
  • [28] A phase I, open-label, multicenter study of cediranib and AZD0530 in patients with advanced solid tumors
    Trarbach, T.
    Drevs, J.
    Strumberg, D.
    Gauler, T. C.
    Schneider, V.
    Eberhardt, W. E.
    Marotti, M.
    Puchalski, T. A.
    Swaisland, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors
    Kouroussis, C
    Kakolyris, S
    Mavroudis, D
    Androulakis, N
    Kalbakis, K
    Agelaki, S
    Sarra, E
    Souglakos, J
    Christodoulakis, M
    Samonis, G
    Georgoulias, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (04): : 404 - 407
  • [30] Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
    Pierre Fumoleau
    Jose Manuel Trigo
    Nicolas Isambert
    Dorothée Sémiond
    Sunil Gupta
    Mario Campone
    BMC Cancer, 13
12345